Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS)

CUSIP: 15117K103

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Ordinary Shares, nominal value EUR0.05 per share
Shares outstanding
95,490,450
Total 13F shares
14,368,296
Share change
+1,204,719
Total reported value
$132,185,088
Price per share
$9.20
Number of holders
60
Value change
+$10,383,968
Number of buys
30
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 15117K103?
CUSIP 15117K103 identifies CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q1 2020

As of 31 Mar 2020, Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,368,296 shares. The largest 10 holders included FMR LLC, ARK Investment Management LLC, Capital International Investors, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., CAPITAL INTERNATIONAL INC /CA/, Capital World Investors, MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., and CREDIT SUISSE AG/. This page lists 60 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.